QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs()()

INTRODUCTION: Many antiviral agents, such as hydroxychloroquine, have been used to treat COVID-19, without being broadly accepted. QTc prolongation is a worrisome adverse effect, scarcely studied in pediatrics. PATIENTS AND METHODS: Paediatric patients affected from COVID-19 who received antivirals...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmel-Vilomara, Roger, Dolader, Paola, Sabaté-Rotes, Anna, Soriano-Arandes, Antoni, Gran, Ferran, Rosés-Noguer, Ferran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Asociación Española de Pediatría. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857946/
https://www.ncbi.nlm.nih.gov/pubmed/35193834
http://dx.doi.org/10.1016/j.anpede.2021.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857946/
https://www.ncbi.nlm.nih.gov/pubmed/35193834
http://dx.doi.org/10.1016/j.anpede.2021.04.006

Ejemplares similares